Abstract:Objective. The genuine causal nexus between mitochondrial function‐related proteins and diabetic nephropathy remains enigmatic and arduous to delineate conclusively. In this study, we employed a bidirectional two‐sample Mendelian randomization analysis, a robust approach, to scrutinize and discern the causal interplay between them. Methods. In this investigation, the datasets pertaining to diabetic nephropathy and mitochondrial function‐related proteins were meticulously extracted from the comprehensive IEU OpenGWAS Project database. The principal analytical method employed was the inverse variance weighted approach. In addition, MR‐Egger regression, simple median, and weighted median methodologies were utilized as supplementary tools to interrogate the causal associations of mitochondrial function‐related proteins with the risk of diabetic nephropathy. Semsitivity analyses were conducted using the Cochran's Q test and MR‐Egger regression intercept. The significance level, as indicated by the P value, was employed as the pivotal metric for interpreting the findings. Result. A total of 90 single nucleotide polymorphisms associated with mitochondrial function‐related proteins were meticulously screened as instrumental variables. The inverse variance weighted analysis unveiled a positive causal nexus between mitochondrial glutamate carrier 2, 2,4‐dienoyl‐CoA reductase mitochondrial levels, 39S ribosomal protein L52 mitochondrial, ATP synthase subunit beta mitochondrial, Serine‐‐tRNA ligase mitochondrial, itochondrial sodium/hydrogen exchanger 9B2, and Esseential MCU regulator mitochondrial, and diabetic nephropathy. Conversely, pyruvate dehydrogenase (acetyl‐transferring) kinase isozyme 1 mitochondrial exhibited a negative causal relationship with diabetic nephropathy., the MR‐Egger intercept test yielded non‐multiplicative results (P > 0.05), affirming the robustness and validity of Mendelian randomization as an effective method for causal inference in this investigation. Furthermore, the reverse Mendelian randomization analysis failed to demonstrate any causal link between diabetic nephropathy and an augmented risk associated with positively identified mitochondrial function‐related proteins. Conclusion. Pyruvate dehydrogenase (acetyl‐transferring) kinase isozyme 1 mitochondrial stands out as an independent protective factor against diabetic nephropathy. The findings bear significant clinical implications, offering pivotal insights into the development of targeted preventive and therapeutic interventions, tailored specifically for combating diabetic nephropathy.

Genetic variants affecting mitochondrial function provide further insights for kidney disease

Contribution of mitochondrial gene variants in diabetes and diabetic kidney disease

Common variants in Mendelian kidney disease genes and their association with renal function

Mitochondrial genetic variation and risk of chronic kidney disease and acute kidney injury in UK Biobank participants

Variations of Mitochondrial Gene ATP6 in Type 2 Diabetes Mellitus

Association between GATM gene polymorphism and progression of chronic kidney disease: a mitochondrial related genome-wide Mendelian randomization study

Mitochondrial DNA: A New Predictor of Diabetic Kidney Disease

Mitochondrial related variants associated with cardiovascular traits

Complexities of Understanding Function from CKD-Associated DNA Variants

Multi-Omic Analysis Reveals Genetic Determinants and Therapeutic Targets of Chronic Kidney Disease and Kidney Function

Roles of Mitochondrial DNA Damage in Kidney Diseases: A New Biomarker

Systematic integrated analysis of genetic and epigenetic variation in diabetic kidney disease

AKR1A1 and Kidney Disease: Promise and Perils of the Multiverse

A clustering approach to improve our understanding of the genetic and phenotypic complexity of chronic kidney disease

Bidirectional Two‐Sample Mendelian Randomization Analysis Unveils a Causal Correlation of Mitochondrial Function‐Related Proteins with the Risk of Diabetic Nephropathy

Associations of genetic variants contributing to gut microbiota composition in diabetic nephropathy

Association Study of Mitochondrial DNA Haplogroup D and C5178A Polymorphisms with Chronic Kidney Disease.

Role of mitochondrial DNA variation in the pathogenesis of diabetes mellitus

Genetic biomarkers of cognitive impairment and dementia of potential interest in CKD patients

Whole-exome sequencing study identifies four novel gene loci associated with diabetic kidney disease

Multivariate canonical correlation analysis identifies additional genetic variants for chronic kidney disease